Cancer is associated with significant health-care expenditure, but few studies have examined the cost of patients with cancer in the intensive care unit (ICU). We aimed to describe the costs and outcomes of patients admitted to the ICU with cancer.
Methods:
We conducted a retrospective cohort study of patients admitted between 2011 and 2016 to 2 tertiary-care ICUs. We included patients with a cancer-related most responsible diagnosis using International Classification of Disease, 10th Revision, Canada codes. We compared costs and outcomes of patients having cancer with noncancer controls matched for age, sex, and Elixhauser comorbidity score. We used logistic regression to determine predictors of mortality among patients with cancer.
Results:
There were 1022 patients with cancer during the study period. Mean age was 63.2 years and 577 (56.5%) were male. Inhospital mortality for all patients with cancer was 24.0%. Total cost per patient was higher for patients with cancer compared to noncancer patients (CAD$57 084 vs CAD$40 730; P < .001) but there were no differences in the cost per day (CAD$2868 vs CAD$2887; P = .76) or ICU cost (CAD$30 495 vs CAD$29 382; P = .42). Among patients with cancer, the cost per day was higher for nonsurvivors (CAD$3477 vs CAD$2677; P < .001). Liver disease (odds ratio [OR]: 2.96; 95% confidence interval [CI]: 1.22-7.81), mechanical ventilation (OR: 1.73; 95% CI: 1.25-2.39), hematologic malignancy (OR: 3.88; 95% CI: 2.31-6.54), and unknown primary site (OR: 2.13; 95% CI: 1.36-3.35) were independently associated with mortality in patients with cancer.
Conclusion:
Patients admitted to the ICU with cancer did not differ in cost per day, ICU cost, or mortality compared to matched noncancer controls. Among patients with cancer, nonsurvivors had significantly higher cost per day compared to survivors. Hematologic and unknown primaries, liver disease, and mechanical ventilation were independently associated with mortality in patients with cancer.
ChastekBBHarleyCKallichJ, et al.Special series: state of oncology practice original contribution health care costs for patients with cancer at the end of Life. J Oncol Pract. 2012;8(6s):75–80.
2.
SudaKJMotlSEKuthJC. Inpatient oncology length of stay and hospital costs: implications for rising inpatient expenditures. J Appl Res. 2006;6(1):126–131.
AzoulayESoaresMDarmonMBenoitDPastoresSAfessaB. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care. 2011;1(5):1–13. doi:10.1186/2110-5820-1-5.
5.
AuclinECharles-NelsonAAbbarB, et al.Outcomes in elderly patients admitted to the intensive care unit with solid tumors. Ann Intensive Care. 2017;7(26):1–8. doi:10.1186/s13613-017-0250-0.
6.
KochACheckleyW. Do hospitals need oncological critical care units?J Thorac Dis. 2017;9(3):E304–E309. doi:10.21037/jtd.2017.03.11.
7.
SoaresMBozzaFAAzevedoLCP, et al.Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care Units. J Clin Oncol. 2016;34:3315–3324. doi:10.1200/JCO.2016.66.9549.
8.
SchapiraD VStudnickiJBradhamDDWolffPJarrettA. Intensive care, survival, and expense of treating critically ill cancer patients. JAMA - J Am Med Assoc. 1993;269(6):783–786. doi:10.1001/jama.1993.03500060083036.
9.
TorresVBLVassaloJSilvaUVA, et al.Outcomes in critically ill patients with cancer-related complications. PLoS One. 2016;11(10):1–14. doi:10.1371/journal.pone.0164537.
10.
FisherRDangoisseCCrichtonS, et al.Short-term and medium-term survival of critically ill patients with solid tumours admitted to the intensive care unit: a retrospective analysis. BMJ Open. 2016;6:e011363. doi:10.1136/bmjopen-2016-011363.
11.
BirdGTFarquhar-SmithPWigmoreTPotterMGruberPC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth. 2012;108(3):452–459. doi:10.1093/bja/aer449.
12.
Abdul-JabbarSBatesIDaviesGShulmanR. An analysis of medicine costs of adult patients on a critical care unit. J Crit Care. 2014;29:472.e7–472.e12. doi:10.1016/j.jcrc.2013.12.014.
13.
HalpernABCulakovaEWalterRBLymanGH. Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit. JAMA Oncol. 2017;3(3):374–381. doi:10.1001/jamaoncol.2016.4858
14.
BloomfieldEL. The impact of economics on changing medical technology with reference to critical care medicine in the United States. Anesth Analg. 2003;96(4):418–425. doi:10.1213/01.ANE.0000031934.78342.0C
15.
HalpernNAPastoresSM. Critical care medicine beds, use, occupancy, and costs in the United States. Crit Care Med. 2015;43(11):2452–2459. doi:10.1097/CCM.0000000000001227.
16.
Canadian Institute for Health Information. Canadian Coding Standards for Version 2018 ICD-10-CA and CCI. Ottawa, ON: CIHI; 2018.
17.
Van WalravenCAustinPCJenningsAQuanHForsterAJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–633. doi:10.1097/MLR.0b013e31819432e5
18.
ElixhauserASteinerCHarrisDCoffeyR. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
19.
Chin-YeeND’EgidioGThavornKHeylandDKyeremantengK. Cost analysis of the very elderly admitted to intensive care units. Crit Care. 2017;21(109):1–7. doi:10.1186/s13054-017-1689-y
20.
FernandoSMReardonPMDowlatshahiD, et al.Outcomes and costs of patients admitted to the ICU due to spontaneous intracranial hemorrhage. Crit Care Med. 2018;46(5):e395–e403. doi:10.1097/CCM.0000000000003013
21.
FernandoSMReardonPMBallIM, et al.Outcomes and costs of patients admitted to the intensive care unit due to accidental or intentional poisoning. J Intensive Care Med. 2018:1–8. doi:10.1177/0885066617754046.
22.
RonksleyPEMcKayJAKobewkaDMMulpuruSForsterAJ. Patterns of health care use in a high-cost inpatient population in Ottawa, Ontario: a retrospective observational study. C Open. 2015;3(1):E111–E118. doi:10.9778/cmajo.20140049
23.
Canadian Institute for Health Information. Canadian Patient Cost Database Technical Document: MIS Patient Costing Methodology January 2019. Ottawa, ON: CIHI; 2019.
24.
JairamVLeeVParkHS, et al.Treatment-Related Complications of Systemic Therapy and Radiotherapy. JAMA Oncol. 2019;5(7):1028–1035. doi:10.1001/jamaoncol.2019.0086
25.
LymanGHCulakovaEPoniewierskiMSKudererNM. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res. 2018;164(2):S112–S118. doi:10.1016/j.thromres.2018.01.028
26.
TanvetyanonTLeightonJC. Life-sustaining treatments in patients who died of chronic congestive heart failure compared with metastatic cancer. Crit Care Med. 2003;31(1):60–64. doi:10.1097/00003246-200301000-00009
27.
BenoitDDVandewoudeKHDecruyenaereJMHosteEAColardynFA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med. 2003;31(1):104–112. doi:10.1097/01.CCM.0000038213.27741.30
28.
LecuyerLChevretSThieryGDarmonMSchlemmerBAzoulayÉ. The ICU Trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med. 2007;35(3):808–814. doi:10.1097/01.CCM.0000256846.27192.7A
29.
WigmoreTFarquhar-SmithP. Outcomes for critically Ill cancer patients in the ICU: current trends and prediction. Int Anesthesiol Clin. 2016;54(4):e62–e75. doi:10.1097/AIA.0000000000000121
30.
DarmonMBourmaudAGeorgesQ, et al.Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med. 2019;45(7):977–987. doi:10.1007/s00134-019-05653-7
31.
KroschinskyFWeiseMIllmerT, et al.Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med. 2002;28(1):1294–1300. doi:10.1007/s00134-002-1420-5
32.
StaudingerTStoiserBMullerMLockerGLaczikaK. Outcome and prognostic factors in critically ill cancer patients admitted to an intensive care unit. Crit Care Med. 2000;28(5):1322–1328. doi:10.3918/jsicm.14.299
33.
WeilDLevesqueEMcPhailM, et al.Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis. Ann Intensive Care. 2017;7(33):1–14. doi:10.1186/s13613-017-0249-6
34.
BarthCSoaresMToffartAC, et al.Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs). Ann Intensive Care. 2018;8(80):1–9. doi:10.1186/s13613-018-0426-2
35.
OstermannMFerrando-VivasPGoreCPowerSHarrisonD.Characteristics and outcome of cancer patients admitted to the ICU in England, Wales, and Northern Ireland and national trends between 1997 and 2013. Crit Care Med. 2017;45(10):1668–1676. doi:10.1097/CCM.0000000000002589
36.
PuxtyKMcLoonePQuasimTKinsellaJMorrisonD. Survival in solid cancer patients following intensive care unit admission. Intensive Care Med. 2014;40(10):1409–1428. doi:10.1007/s00134-014-3471-9
37.
HampshirePAWelchCAMcCrossanLAFrancisKHarrisonDA. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC case mix programme database. Crit Care. 2009;13(4):R137. doi:10.1186/cc8016
38.
QuanHLiBDuncan SaundersL, et al.Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43(4):1424–1441. doi:10.1111/j.1475-6773.2007.00822.x
39.
HwangYParkSAhnSLeeJParkYKimN. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: a retrospective large-cohort study. World J Gastroenterol. 2019;25(37):5619–5629.
40.
MehtaHBSuraSDAdhikariD, et al.Adapting the Elixhauser comorbidity index for cancer patients. Cancer. 2018;124(9):2018–2025. doi:10.1002/cncr.31269
41.
LieffersJRBaracosVEWingetMFassbenderK. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer. 2011;117(9):1957–1965. doi:10.1002/cncr.25653
